The program is designed to review the critical elements of oral oncology focusing on the early detection of oral cancer and the provision of oral health care to patients who have received radiation, chemotherapy or anti-resorptive agents that are associated with osteonecrosis.
Learning Objectives: At the conclusion of this session, participants will be able to:
1. Identify the risk factors, high risk sites and early appearance of oral cancer;
2. Discuss the impact of radiation and chemotherapy on oral health care;
3. Describe the effect of anti-resorptive agents on the jaws and outline a strategy for management of patients on these drugs
Credits: 3 CEU’s [AGD Code: #734]
Instructor: Dr. Hillel Ephros, DMD, MD, Chairman, Department of Dentistry / Oral & Maxillofacial Surgery, Medical Director of the Regional Craniofacial Center and Residency Program Director, Oral & Maxillofacial Surgery, St. Joseph’s Regional Medical Center. Former examiner for the American Board of Oral & Maxillofacial Surgery, Adjunct Professor, New York Medical College and adjunct faculty member, Columbia University and Rutgers Dental School